Nirmal Raut, Senior Consultant in Medical Oncology at HCG Cancer Centre Mumbai, shared on X:
“M/65 years Stage IV NSCLC
mEGFR – Osimertinib x 2 years. Prog disease – liquid Bx sent. WWYD ?
- Imatinib
- Lorlatinib
- Imatinib + Lorlatinib
- Osimertinib + Lorlatinib + Imatinib
- Pem/carbo +/- Osi.”
You might be interested in:
Up-Front NGS in Advanced NSCLC: Real-World Data Link Earlier Molecular Testing to Longer Survival
